Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,401 | 25,293 | 39,143 | 72,184 | 43,446 |
| Marketable Securities | 328,416 | 355,175 | 369,107 | 350,905 | 120,591 |
| Receivables | 97 | 243 | 172 | 197 | 496 |
| TOTAL | $367,979 | $390,699 | $410,839 | $426,555 | $167,606 |
| Non-Current Assets | |||||
| PPE Net | 3,744 | 3,484 | 3,551 | 3,342 | 3,496 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 30,690 |
| Other Non-Current Assets | 4,048 | 2,668 | 3,074 | 3,114 | 2,759 |
| TOTAL | $34,982 | $33,342 | $33,815 | $33,646 | $36,945 |
| Total Assets | $402,961 | $424,041 | $444,654 | $460,201 | $204,551 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,721 | N/A |
| Accounts payable and accrued liabilities | 15,902 | 1,019 | 1,228 | 836 | 685 |
| Accrued Expenses | 11,229 | 9,234 | 12,000 | 10,253 | 7,851 |
| Other current liabilities | 1,393 | 2,505 | 1,554 | N/A | 4,621 |
| TOTAL | $29,949 | $14,560 | $16,528 | $14,176 | $14,488 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 1,296 | N/A | N/A |
| Other Non-Current Liabilities | 7,919 | 11,380 | 7,354 | 9,313 | 7,781 |
| TOTAL | $7,919 | $11,380 | $8,650 | $9,313 | $7,781 |
| Total Liabilities | $37,868 | $25,940 | $25,178 | $23,489 | $22,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,772 | 46,754 | 46,735 | 46,664 | 46,482 |
| Common Shares | 47 | 47 | 47 | 47 | 40 |
| Retained earnings | -1,202,661 | -1,166,657 | -1,143,607 | -1,123,459 | -1,103,007 |
| Other shareholders' equity | -417 | 112 | 1,894 | 2,548 | 2,592 |
| TOTAL | $365,093 | $398,101 | $419,476 | $436,712 | $182,282 |
| Total Liabilities And Equity | $402,961 | $424,041 | $444,654 | $460,201 | $204,551 |